Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, Matsuo N, Ichikawa K, Iwasaki K, Naito T, Namba Y, Yoshida M, Sugiyama H, Ito H.
Int J Mol Sci. 2022 Mar 25;23(7):3587. doi: 10.3390/ijms23073587.
Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M, Li Y, Li S, Lv J.
Front Endocrinol (Lausanne). 2022 Apr 7;13:851941. doi: 10.3389/fendo.2022.851941. eCollection 2022.
Molecular mechanisms of diabetic cardiomyopathy.
Bugger H, Abel ED.
Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30.
Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53.
Tang YJ, Zhang Z, Yan T, Chen K, Xu GF, Xiong SQ, Wu DQ, Chen J, Jose PA, Zeng CY, Fu JJ.
Cardiovasc Diabetol. 2024 Apr 2;23(1):116. doi: 10.1186/s12933-024-02183-5.
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.
Ng ACT, Delgado V, Borlaug BA, Bax JJ.
Nat Rev Cardiol. 2021 Apr;18(4):291-304. doi: 10.1038/s41569-020-00465-5. Epub 2020 Nov 13.
Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancestry.
Zhao Y, Quan E, Zeng T, Huang Z, Luo Y, Peng L, Li S, Liu J, Chong Y, Cao H.
Cardiovasc Diabetol. 2024 Jan 13;23(1):31. doi: 10.1186/s12933-023-02117-7.
Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus.
Sha W, Hu F, Xi Y, Chu Y, Bu S.
J Diabetes Res. 2021 Jun 28;2021:9999612. doi: 10.1155/2021/9999612. eCollection 2021.
[Diabetic miocardiopathy].
Gil-Ortega I, Carlos Kaski J.
Med Clin (Barc). 2006 Oct 21;127(15):584-94. doi: 10.1157/13094003.
Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
Tanaka H, Tatsumi K, Matsuzoe H, Matsumoto K, Hirata KI.
Cardiovasc Diabetol. 2020 Jun 13;19(1):84. doi: 10.1186/s12933-020-01063-y.
Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non-Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study.
Zhang HK, Du Y, Shi CY, Zhang N, Gao HQ, Zhong YL, Wang MZ, Zhou Z, Gao XL, Li S, Yang L, Liu T, Fan ZM, Sun ZH, Xu L.
J Magn Reson Imaging. 2024 Jan;59(1):164-176. doi: 10.1002/jmri.28723. Epub 2023 Apr 4.
